Biotechnological Based Recombinant Protein Vaccines Developed Against Toxoplasmosis

Biotechnological Based Recombinant Protein Vaccines Developed Against Toxoplasmosis

Toxoplasma gondii (T. gondii) that can infect most warm-blooded animals and humans, is an obligate intracellular apicomplexan parasite with a wide host range. About one-third of the world’s population is infected with this parasite. While toxoplasmosis progresses asymptomatically in individuals with...

Full description

Bibliographic Details
Main Authors: Tuğba Karakavuk, Ceren Gül, Muhammet Karakavuk, Aytül Gül, Sedef Erkunt Alak, Hüseyin Can, Cemal Ün, Mert Döşkaya, Adnan Yüksel Gürüz, Aysu Değirmenci Döşkaya
Format: Article
Language:English
Published: Galenos Yayinevi 2022-12-01
Series:Türkiye Parazitoloji Dergisi
Subjects:
toxoplasma gondii
recombinant protein vaccines
biotechnology
immunization
Online Access: http://www.turkiyeparazitolderg.org/archives/archive-detail/article-preview/biotechnological-based-recombinant-protein-vaccine/57299

Internet

http://www.turkiyeparazitolderg.org/archives/archive-detail/article-preview/biotechnological-based-recombinant-protein-vaccine/57299

Similar Items